Matrix metalloproteinase-3 is a possible mediator of neurodevelopmental impairment due to polyI: C-induced innate immune activation of astrocytes

Brain, Behavior, and Immunity

Volumn 38, Issue , 2014, Pages 272-282

  Yamada, Shinnosuke ^a   Nagai, Taku ^a   Nakai, Tsuyoshi ^a   Ibi, Daisuke ^a   Nakajima, Akira ^a   Yamada, Kiyofumi ^a  

^a NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Astrocyte; Cytokine; Immune response; Mmp3; Neuron; Neuron glia interactions; PolyI:C; Schizophrenia; Secretome; Viral infection

Indexed keywords

ALPHA ENOLASE; BETA N ACETYLHEXOSAMINIDASE; CATHEPSIN B; CATHEPSIN D; COACTOSIN LIKE PROTEIN; CREATINE KINASE; CREATINE KINASE B; FOLLISTATIN RELATED PROTEIN; GALECTIN 1; GLIA MATURATION FACTOR; GLUTATHIONE TRANSFERASE A4; GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE P1; HUMORAL ANTIBODY; INITIATION FACTOR 5A; LACTATE DEHYDROGENASE; MESSENGER RNA; PIGMENT EPITHELIUM DERIVED FACTOR; POLYINOSINIC POLYCYTIDYLIC ACID; PROTEIN DISULFIDE ISOMERASE; PROTEIN DISULFIDE ISOMERASE A6; SERPIN B6; SMALL INTERFERING RNA; STROMELYSIN; UNCLASSIFIED DRUG; MMP3 PROTEIN, MOUSE;

ANIMAL CELL; ARTICLE; ASTROCYTE; ASTROCYTE CULTURE; CELL ACTIVATION; CELL ELONGATION; CONTROLLED STUDY; DEVELOPMENTAL DISORDER; ENZYME ACTIVITY; FLUORESCENCE; HIPPOCAMPAL NEURONAL CULTURE; INNATE IMMUNITY; MOUSE; NERVE CELL DIFFERENTIATION; NEURITE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEOMICS; QUANTITATIVE ANALYSIS; TWO DIMENSIONAL DIFFERENCE GEL ELECTROPHORESIS; UPREGULATION; ANIMAL TISSUE; DENDRITE; EMBRYO; HIPPOCAMPUS; MICROGLIA; NEURITE OUTGROWTH; NEWBORN; ANIMAL; C57BL MOUSE; CELL CULTURE; DRUG EFFECTS; ENZYMOLOGY; IMMUNOLOGY; METABOLISM;

ANIMALS; ASTROCYTES; CELLS, CULTURED; IMMUNITY, INNATE; MATRIX METALLOPROTEINASE 3; MICE; MICE, INBRED C57BL; MICROGLIA; POLY I-C; UP-REGULATION;

EID: 84898545922     PISSN: 08891591     EISSN: 10902139     Source Type: Journal    
DOI: 10.1016/j.bbi.2014.02.014     Document Type: Article

References (60)

1. Alexopoulou L., Holt A.C., Medzhitov R., Flavell R.A. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3. Nature 2001, 413:732-738.
2. Asundi V.K., Erdman R., Stahl R.C., Carey D.J. Matrix metalloproteinase-dependent shedding of syndecan-3, a transmembrane heparan sulfate proteoglycan, in Schwann cells. J. Neurosci. Res. 2003, 73:593-602.
3. Brown A.S. The environment and susceptibility to schizophrenia. Prog. Neurobiol. 2011, 93:23-58.
4. Brown A.S., Begg M.D., Gravenstein S., Schaefer C.A., Wyatt R.J., Bresnahan M., Babulas V.P., Susser E.S. Serologic evidence of prenatal influenza in the etiology of schizophrenia. Arch. Gen. Psychiatry 2004, 61:774-780.
5. Chakraborti S., Mandal M., Das S., Mandal A., Chakraborti T. Regulation of matrix metalloproteinases: an overview. Mol. Cell. Biochem. 2003, 253:269-285.
6. Choi D.H., Kim Y.J., Kim Y.G., Joh T.H., Beal M.F., Kim Y.S. Role of matrix metalloproteinase 3-mediated alpha-synuclein cleavage in dopaminergic cell death. J. Biol. Chem. 2011, 286:14168-14177.
7. Cordero-Llana O., Scott S.A., Maslen S.L., Anderson J.M., Boyle J., Chowhdury R.R., Tyers P., Barker R.A., Kelly C.M., Rosser A.E., Stephens E., Chandran S., Caldwell M.A. Clusterin secreted by astrocytes enhances neuronal differentiation from human neural precursor cells. Cell Death Differ. 2011, 18:907-913.
8. Crocker S.J., Milner R., Pham-Mitchell N., Campbell I.L. Cell and agonist-specific regulation of genes for matrix metalloproteinases and their tissue inhibitors by primary glial cells. J. Neurochem. 2006, 98:812-823.
9. Cross-Disorder Group of the Psychiatric Genomics C., Smoller J.W., Kendler K., Lee P.H., Neale B.M., Nurnberger J.I., Ripke S., Santangelo S., Sullivan P.F. Identification of risk loci with shared effects on five major psychiatric disorders: a genome-wide analysis. Lancet 2013, 381:1371-1379.
10. Dean K., Murray R.M. Environmental risk factors for psychosis. Dialogues Clin. Neurosci. 2005, 7:69-80.
11. Delcourt N., Jouin P., Poncet J., Demey E., Mauger E., Bockaert J., Marin P., Galeotti N. Difference in mass analysis using labeled lysines (DIMAL-K): a new, efficient proteomic quantification method applied to the analysis of astrocytic secretomes. Mol. Cell. Proteomics 2005, 4:1085-1094.
12. Dong Y., Benveniste E.N. Immune function of astrocytes. Glia 2001, 36:180-190.
13. Ethell I.M., Ethell D.W. Matrix metalloproteinases in brain development and remodeling: synaptic functions and targets. J. Neurosci. Res. 2007, 85:2813-2823.
14. Flex A., Giovannini S., Biscetti F., Liperoti R., Spalletta G., Straface G., Landi F., Angelini F., Caltagirone C., Ghirlanda G., Bernabei R. Effect of proinflammatory gene polymorphisms on the risk of Alzheimer's disease. Neurodegener. Dis. 2013, 10.1159/000353395.
15. Fortier M.E., Kent S., Ashdown H., Poole S., Boksa P., Luheshi G.N. The viral mimic, polyinosinic:polycytidylic acid, induces fever in rats via an interleukin-1-dependent mechanism. Am. J. Physiol. Regul. Integr. Comp. Physiol. 2004, 287:R759-R766.
16. Grabrucker A.M. Environmental factors in autism. Front. Psychiatry 2012, 3:118.
17. Hamilton N.B., Attwell D. Do astrocytes really exocytose neurotransmitters?. Nat. Rev. Neurosci. 2010, 11:227-238.
18. He F., Sun Y.E. Glial cells more than support cells?. Int. J. Biochem. Cell Biol. 2007, 39:661-665.
19. Horvath S., Mirnics K. Immune system disturbances in Schizophrenia. Biol. Psychiatry 2014, 75:316-323.
20. Ibi D., Nagai T., Kitahara Y., Mizoguchi H., Koike H., Shiraki A., Takuma K., Kamei H., Noda Y., Nitta A., Nabeshima T., Yoneda Y., Yamada K. Neonatal polyI: C treatment in mice results in schizophrenia-like behavioral and neurochemical abnormalities in adulthood. Neurosci. Res. 2009, 64:297-305.
21. Ibi D., Nagai T., Nakajima A., Mizoguchi H., Kawase T., Tsuboi D., Kano S., Sato Y., Hayakawa M., Lange U.C., Adams D.J., Surani M.A., Satoh T., Sawa A., Kaibuchi K., Nabeshima T., Yamada K. Astroglial IFITM3 mediates neuronal impairments following neonatal immune challenge in mice. Glia 2013, 61:679-693.
22. Ito S., Kimura K., Haneda M., Ishida Y., Sawada M., Isobe K. Induction of matrix metalloproteinases (MMP3, MMP12 and MMP13) expression in the microglia by amyloid-beta stimulation via the PI3K/Akt pathway. Exp. Gerontol. 2007, 42:532-537.
23. Keene S.D., Greco T.M., Parastatidis I., Lee S.H., Hughes E.G., Balice-Gordon R.J., Speicher D.W., Ischiropoulos H. Mass spectrometric and computational analysis of cytokine-induced alterations in the astrocyte secretome. Proteomics 2009, 9:768-782.
24. Khandaker G.M., Zimbron J., Dalman C., Lewis G., Jones P.B. Childhood infection and adult schizophrenia: a meta-analysis of population-based studies. Schizophr. Res. 2012, 139:161-168.
25. Kim E.M., Shin E.J., Choi J.H., Son H.J., Park I.S., Joh T.H., Hwang O. Matrix metalloproteinase-3 is increased and participates in neuronal apoptotic signaling downstream of caspase-12 during endoplasmic reticulum stress. J. Biol. Chem. 2010, 285:16444-16452.
26. Kim S.T., Kim E.M., Choi J.H., Son H.J., Ji I.J., Joh T.H., Chung S.J., Hwang O. Matrix metalloproteinase-3 contributes to vulnerability of the nigral dopaminergic neurons. Neurochem. Int. 2010, 56:161-167.
27. Kim Y.S., Choi D.H., Block M.L., Lorenzl S., Yang L., Kim Y.J., Sugama S., Cho B.P., Hwang O., Browne S.E., Kim S.Y., Hong J.S., Beal M.F., Joh T.H. A pivotal role of matrix metalloproteinase-3 activity in dopaminergic neuronal degeneration via microglial activation. FASEB J. 2007, 21:179-187.
28. Kucukali C.I., Aydin M., Ozkok E., Bilge E., Orhan N., Zengin A., Kara I. Do schizophrenia and bipolar disorders share a common disease susceptibility variant at the MMP3 gene?. Prog. Neuropsychopharmacol. Biol. Psychiatry 2009, 33:557-561.
29. Lafon-Cazal M., Adjali O., Galeotti N., Poncet J., Jouin P., Homburger V., Bockaert J., Marin P. Proteomic analysis of astrocytic secretion in the mouse. Comparison with the cerebrospinal fluid proteome. J. Biol. Chem. 2003, 278:24438-24448.
30. Lai W., Wu J., Zou X., Xie J., Zhang L., Zhao X., Zhao M., Wang Q., Ji J. Secretome analyses of Abeta(1-42) stimulated hippocampal astrocytes reveal that CXCL10 is involved in astrocyte migration. J. Proteome Res. 2013, 12:832-843.
31. Levin J., Giese A., Boetzel K., Israel L., Hogen T., Nubling G., Kretzschmar H., Lorenzl S. Increased alpha-synuclein aggregation following limited cleavage by certain matrix metalloproteinases. Exp. Neurol. 2009, 215:201-208.
32. Mercapide J., Lopez De Cicco R., Castresana J.S., Klein-Szanto A.J. Stromelysin-1/matrix metalloproteinase-3 (MMP-3) expression accounts for invasive properties of human astrocytoma cell lines. Int. J. Cancer 2003, 106:676-682.
33. Meyer U., Feldon J. Epidemiology-driven neurodevelopmental animal models of schizophrenia. Prog. Neurobiol. 2010, 90:285-326.
34. Meyer U., Feldon J., Schedlowski M., Yee B.K. Towards an immuno-precipitated neurodevelopmental animal model of schizophrenia. Neurosci. Biobehav. Rev. 2005, 29:913-947.
35. Moore N.H., Costa L.G., Shaffer S.A., Goodlett D.R., Guizzetti M. Shotgun proteomics implicates extracellular matrix proteins and protease systems in neuronal development induced by astrocyte cholinergic stimulation. J. Neurochem. 2009, 108:891-908.
36. Nagai T., Ibi D., Yamada K. Animal model for schizophrenia that reflects gene-environment interactions. Biol. Pharm. Bull. 2011, 34:1364-1368.
37. Nawa H., Takei N. Recent progress in animal modeling of immune inflammatory processes in schizophrenia: implication of specific cytokines. Neurosci. Res. 2006, 56:2-13.
38. Noe V., Fingleton B., Jacobs K., Crawford H.C., Vermeulen S., Steelant W., Bruyneel E., Matrisian L.M., Mareel M. Release of an invasion promoter E-cadherin fragment by matrilysin and stromelysin-1. J. Cell Sci. 2001, 114:111-118.
39. O'Callaghan E., Sham P.C., Takei N., Murray G., Glover G., Hare E.H., Murray R.M. The relationship of schizophrenic births to 16 infectious diseases. Br. J. Psychiatry 1994, 165:353-356.
40. Olson J.K., Miller S.D. Microglia initiate central nervous system innate and adaptive immune responses through multiple TLRs. J. Immunol. 2004, 173:3916-3924.
41. Ozawa K., Hashimoto K., Kishimoto T., Shimizu E., Ishikura H., Iyo M. Immune activation during pregnancy in mice leads to dopaminergic hyperfunction and cognitive impairment in the offspring: a neurodevelopmental animal model of schizophrenia. Biol. Psychiatry 2006, 59:546-554.
42. Pletnikov M.V., Rubin S.A., Vasudevan K., Moran T.H., Carbone K.M. Developmental brain injury associated with abnormal play behavior in neonatally Borna disease virus-infected Lewis rats: a model of autism. Behav. Brain Res. 1999, 100:43-50.
43. Revello M.G., Gerna G. Pathogenesis and prenatal diagnosis of human cytomegalovirus infection. J. Clin. Virol. 2004, 29:71-83.
44. Ripke S., O'Dushlaine C., Chambert K., Moran J.L., Kahler A.K., Akterin S., Bergen S.E., Collins A.L., Crowley J.J., Fromer M., Kim Y., Lee S.H., Magnusson P.K., Sanchez N., Stahl E.A., Williams S., Wray N.R., Xia K., Bettella F., Borglum A.D., Bulik-Sullivan B.K., Cormican P., Craddock N., de Leeuw C., Durmishi N., Gill M., Golimbet V., Hamshere M.L., Holmans P., Hougaard D.M., Kendler K.S., Lin K., Morris D.W., Mors O., Mortensen P.B., Neale B.M., O'Neill F.A., Owen M.J., Milovancevic M.P., Posthuma D., Powell J., Richards A.L., Riley B.P., Ruderfer D., Rujescu D., Sigurdsson E., Silagadze T., Smit A.B., Stefansson H., Steinberg S., Suvisaari J., Tosato S., Verhage M., Walters J.T., Multicenter GeneticStudies of Schizophrenia C., Levinson D.F., Gejman P.V., Kendler K.S., Laurent C., Mowry B.J., O'Donovan M.C., Owen M.J., Pulver A.E., Riley B.P., Schwab S.G., Wildenauer D.B., Dudbridge F., Holmans P., Shi J., Albus M., Alexander M., Campion D., Cohen D., Dikeos D., Duan J., Eichhammer P., Godard S., Hansen M., Lerer F.B., Liang K.Y., Maier W., Mallet J., Nertney D.A., Nestadt G., Norton N., O'Neill F.A., Papadimitriou G.N., Ribble R., Sanders A.R., Silverman J.M., Walsh D., Williams N.M., Wormley B., Psychosis Endophenotypes International C., Arranz M.J., Bakker S., Bender S., Bramon E., Collier D., Crespo-Facorro B., Hall J., Iyegbe C., Jablensky A., Kahn R.S., Kalaydjieva L., Lawrie S., Lewis C.M., Lin K., Linszen D.H., Mata I., McIntosh A., Murray R.M., Ophoff R.A., Powell J., Rujescu D., Van Os J., Walshe M., Weisbrod M., Wiersma D., Wellcome Trust Case Control Management C., Donnelly P., Barroso I., Blackwell J.M., Bramon E., Brown M.A., Casas J.P., Corvin A.P., Deloukas P., Duncanson A., Jankowski J., Markus H.S., Mathew C.G., Palmer C.N., Plomin R., Rautanen A., Sawcer S.J., Trembath R.C., Viswanathan A.C., Wood N.W., Data Analysis G., Spencer C.C., Band G., Bellenguez C., Freeman C., Hellenthal G., Giannoulatou E., Pirinen M., Pearson R.D., Strange A., Su Z., Vukcevic D., Donnelly P., Dna G.D.Q.C., Informatics G., Langford C., Hunt S.E., Edkins S., Gwilliam R., Blackburn H., Bumpstead S.J., Dronov S., Gillman M., Gray E., Hammond N., Jayakumar A., McCann O.T., Liddle J., Potter S.C., Ravindrarajah R., Ricketts M., Tashakkori-Ghanbaria A., Waller M.J., Weston P., Widaa S., Whittaker P., Barroso I., Deloukas P., Publications C., Mathew C.G., Blackwell J.M., Brown M.A., Corvin A.P., McCarthy M.I., Spencer C.C., Bramon E., Corvin A.P., O'Donovan M.C., Stefansson K., Scolnick E., Purcell S., McCarroll S.A., Sklar P., Hultman C.M., Sullivan P.F. Genome-wide association analysis identifies 13 new risk loci for schizophrenia. Nat. Genet. 2013, 45:1150-1159.
45. Rubin S.A., Sylves P., Vogel M., Pletnikov M., Moran T.H., Schwartz G.J., Carbone K.M. Borna disease virus-induced hippocampal dentate gyrus damage is associated with spatial learning and memory deficits. Brain Res. Bull. 1999, 48:23-30.
46. Schmidt-Kastner R., van Os J., Esquivel G., Steinbusch H.W., Rutten B.P. An environmental analysis of genes associated with schizophrenia: hypoxia and vascular factors as interacting elements in the neurodevelopmental model. Mol. Psychiatry 2012, 17:1194-1205.
47. Schulze-Tanzil G., de Souza P., Merker H.J., Shakibaei M. Co-localization of integrins and matrix metalloproteinases in the extracellular matrix of chondrocyte cultures. Histol. Histopathol. 2001, 16:1081-1089.
48. Shi L., Fatemi S.H., Sidwell R.W., Patterson P.H. Maternal influenza infection causes marked behavioral and pharmacological changes in the offspring. J. Neurosci. 2003, 23:297-302.
49. Skorupa A., Urbach S., Vigy O., King M.A., Chaumont-Dubel S., Prehn J.H., Marin P. Angiogenin induces modifications in the astrocyte secretome: relevance to amyotrophic lateral sclerosis. J. Proteomics 2013, 91C:274-285.
50. Smith S.E., Li J., Garbett K., Mirnics K., Patterson P.H. Maternal immune activation alters fetal brain development through interleukin-6. J. Neurosci. 2007, 27:10695-10702.
51. Takeuchi O., Akira S. Recognition of viruses by innate immunity. Immunol. Rev. 2007, 220:214-224.
52. Town T., Jeng D., Alexopoulou L., Tan J., Flavell R.A. Microglia recognize double-stranded RNA via TLR3. J. Immunol. 2006, 176:3804-3812.
53. Ullian E.M., Christopherson K.S., Barres B.A. Role for glia in synaptogenesis. Glia 2004, 47:209-216.
54. van Dongen J., Boomsma D.I. The evolutionary paradox and the missing heritability of schizophrenia. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2013, 162B:122-136.
55. Volterra A., Meldolesi J. Astrocytes, from brain glue to communication elements: the revolution continues. Nat. Rev. Neurosci. 2005, 6:626-640.
56. Walters J.T., Rujescu D., Franke B., Giegling I., Vasquez A.A., Hargreaves A., Russo G., Morris D.W., Hoogman M., Da Costa A., Moskvina V., Fernandez G., Gill M., Corvin A., O'Donovan M.C., Donohoe G., Owen M.J. The role of the major histocompatibility complex region in cognition and brain structure: a schizophrenia GWAS follow-up. Am. J. Psychiatry 2013, 170:877-885.
57. Wang D.D., Bordey A. The astrocyte odyssey. Prog. Neurobiol. 2008, 86:342-367.
58. Witek-Zawada B., Koj A. Regulation of expression of stromyelysin-1 by proinflammatory cytokines in mouse brain astrocytes. J. Physiol. Pharmacol. 2003, 54:489-496.
59. Yan E., Castillo-Melendez M., Nicholls T., Hirst J., Walker D. Cerebrovascular responses in the fetal sheep brain to low-dose endotoxin. Pediatr. Res. 2004, 55:855-863.
60. Ye S., Eriksson P., Hamsten A., Kurkinen M., Humphries S.E., Henney A.M. Progression of coronary atherosclerosis is associated with a common genetic variant of the human stromelysin-1 promoter which results in reduced gene expression. J. Biol. Chem. 1996, 271:13055-13060.